Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) has disclosed Goodwill for 4 consecutive years, with $785000.0 as the latest value for Q4 2019.

  • Quarterly Goodwill changed 0.0% to $785000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $785000.0 through Dec 2019, changed 0.0% year-over-year, with the annual reading at $785000.0 for FY2019, 0.0% changed from the prior year.
  • Goodwill hit $785000.0 in Q4 2019 for Ironwood Pharmaceuticals, roughly flat from $785000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $785000.0 in Q4 2016 to a low of $649000.0 in Q2 2016.
  • Historically, Goodwill has averaged $766866.7 across 4 years, with a median of $785000.0 in 2016.
  • Biggest YoY gain for Goodwill was 20.96% in 2017; the steepest drop was 0.0% in 2017.
  • Year by year, Goodwill stood at $785000.0 in 2016, then changed by 0.0% to $785000.0 in 2017, then changed by 0.0% to $785000.0 in 2018, then changed by 0.0% to $785000.0 in 2019.
  • Business Quant data shows Goodwill for IRWD at $785000.0 in Q4 2019, $785000.0 in Q3 2019, and $785000.0 in Q2 2019.